Loss of Atrx Sensitizes Cells to DNA Damaging Agents through p53-Mediated Death Pathways

• Damiano Conte,

  Affiliation Regenerative Medicine Program, Ottawa Hospital Research Institute, Ottawa, Ontario, Canada

  ⨯
• Michael Huh,

  Affiliation Regenerative Medicine Program, Ottawa Hospital Research Institute, Ottawa, Ontario, Canada

  ⨯
• Emma Goodall,

  Affiliations Regenerative Medicine Program, Ottawa Hospital Research Institute, Ottawa, Ontario, Canada, Department of Cellular and Molecular Medicine, University of Ottawa, Ottawa, Ontario, Canada

  ⨯
• Marilyne Delorme,

  Affiliations Regenerative Medicine Program, Ottawa Hospital Research Institute, Ottawa, Ontario, Canada, Department of Biochemistry Microbiology and Immunology, University of Ottawa, Ontario, Canada

  ⨯
• Robin J. Parks,

  Affiliations Regenerative Medicine Program, Ottawa Hospital Research Institute, Ottawa, Ontario, Canada, Department of Biochemistry Microbiology and Immunology, University of Ottawa, Ontario, Canada, Department of Medicine, University of Ottawa, Ottawa, Ontario, Canada

  ⨯
• David J. Picketts

  * E-mail: dpicketts@ohri.ca

  Affiliations Regenerative Medicine Program, Ottawa Hospital Research Institute, Ottawa, Ontario, Canada, Department of Biochemistry Microbiology and Immunology, University of Ottawa, Ontario, Canada, Department of Medicine, University of Ottawa, Ottawa, Ontario, Canada

  ⨯